Loading...
NASDAQ: IDXX
IDEXX Laboratories, Inc.
Healthcare · Medical - Diagnostics & Research
●S&P 500 since 2017
Market Cap
$46.08B
52w High
$769.98
52w Low
$356.14
P/E
43.63
Volume
514.83K
Outstanding Shares
79.85M
Company profile
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide.
CEOJonathan J. Mazelsky
SectorHealthcare
IndustryMedical - Diagnostics & Research
Employees11,000
IPO dateJun 21, 1991
Valuation
Forward P/E—
EV/EBITDA37.50
Enterprise value$55.08B
Stock splits
Jun 16, 20152:1
Nov 27, 20072:1
Jun 6, 19952:1
Oct 4, 19932:1
Profitability & growth
Revenue growth14.28%
Gross margin61.8%▲1.25%vs FY2024
Operating margin31.6%▲9.16%vs FY2024
ROE65.99%▲18.58%vs FY2024
Analyst consensus
RatingBuy
Target price$784.38▲35.91%
13
Buy
8
Hold
1
Sell
⚠ Analyst ratings tend to be lagging indicators — upgrades often follow price gains rather than precede them. Use as one signal among many.
Earnings
Last 3 reported quarters plus the next estimate. Switch into compare mode to inspect one metric year-over-year.
Next report
May 7, 2026
View
EPS
Actual vs estimate by quarter
Q2FY25
ActualEst.
$3.63
$3.28
Q3FY25
ActualEst.
$3.40
$3.14
Q4FY25
ActualEst.
$3.08
$2.93
Q1FY26
Next Est.
—
Revenue
Actual vs estimate by quarter
Q2FY25
ActualEst.
$1.11B
$1.06B
Q3FY25
ActualEst.
$1.11B
$1.07B
Q4FY25
ActualEst.
$1.09B
$1.07B
Q1FY26
Next Est.
—